Gilead Sciences Inc (NAS:GILD)
$ 67.9 0.18 (0.27%) Market Cap: 84.59 Bil Enterprise Value: 104.85 Bil PE Ratio: 188.61 PB Ratio: 4.83 GF Score: 74/100

Gilead Sciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript

May 19, 2021 / 02:20PM GMT
Release Date Price: $68.5 (-0.51%)
Brian Corey Abrahams
RBC Capital Markets, Research Division - Senior Biotechnology Analyst

Good morning, everyone. I'm Brian Abrahams, senior biotech analyst at RBC Capital Markets. Very pleased to have our next presenting company, Gilead, represented by their CFO, Andy Dickinson. Andy, thanks so much for joining us.

Andrew D. Dickinson
Gilead Sciences, Inc. - Executive VP & CFO

Thanks, Brian. I appreciate you having us. Happy to be here.

Questions & Answers

Brian Corey Abrahams
RBC Capital Markets, Research Division - Senior Biotechnology Analyst

Absolutely. Our pleasure. So maybe just kicking things off, coming off of a seasonally soft first quarter, with COVID exacerbating some of the usual dynamics. How are you -- what's the outlook for the rest of the year? How are you expecting things to progress? And what are you seeing that gives you confidence in a bounce-back?

Andrew D. Dickinson
Gilead Sciences, Inc. - Executive VP & CFO

Yes. That's a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot